Comparison
OPTAVIA vs Tenlead Biotech
Every figure links back to its source on the company profiles. Empty cells mean we have no verified figure, not zero.
| Metric | OPTAVIA | Tenlead Biotech |
|---|---|---|
| Category | Health & nutrition, Food & beverage | Health & nutrition |
| Headquarters | Baltimore, Maryland, United States | Taiwan |
| Founded | 1980 | — |
| Ownership | Public (NYSE: MED) | Private |
| Compensation plan | Stairstep breakaway | — |
| Revenue (latest) | $386M 2025 Reported | $200M 2025 Reported |
| Markets on record | — | 3 |
| Income disclosure | 2025 (US) | None on record |
| Median annual earnings | — | — |
| Share earning under $500 | 57.3% | — |
| Share earning nothing | 23.3% | — |
| Top 1% share of payouts | — | — |
| Regulatory/legal events on record | 1 | 0 |
Revenue as reported to public lists or filings. Income disclosure figures are gross payments as stated by each company and are only comparable when both statements count the same participants; see each company's income page for the notes.